Acute Myeloid Leukemia (AML): Relapse
Acute Myeloid Leukemia (AML): Relapse
There are an increasing number of options available for AML relapse; this section identifies some of the important topics around recurrence and the available treatments
- Relapse is a part of the journey for many AML patients
- The timing of relapse will be a big part of making treatment decisions
- Monitoring health after initial treatment is crucial for people with AML
Relapse : Symptoms & Diagnosis
- Relapse is a part of the journey for many AML patients
- The timing of relapse will be a big part of making treatment decisions
- Monitoring health after initial treatment is crucial for people with AML
Treatment
"Unfortunately for many patients with AML, their disease will come back and we call that a disease relapse," says Dr. Tara Lin, director, Acute Leukemia Program, University of Kansas Medical Center. "It's really important that when a patient has relapse of their disease that they see someone who has a lot of experience... Read More
- Drugs such as Ivosidenib or Enasidenib can be given to help achieve remission in patients with relapsed AML
- Recently approved drugs, like FLT3-inhibitor Gilteritinib, have also shown great promise in treating relapsed disease
Relapse : Exploring the Options
- Drugs such as Ivosidenib or Enasidenib can be given to help achieve remission in patients with relapsed AML
- Recently approved drugs, like FLT3-inhibitor Gilteritinib, have also shown great promise in treating relapsed disease